These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. The significance of sodium in renal stone formation. Fogarty AJ Br J Urol; 1971 Aug; 43(4):403-5. PubMed ID: 5095571 [No Abstract] [Full Text] [Related]
27. Urinary excretion of calcium and magnesium in primary hyperparathyroidism. Sutton RA; Watson L Lancet; 1969 May; 1(7603):1000-3. PubMed ID: 4181166 [No Abstract] [Full Text] [Related]
28. Effect of prolonged bedrest on the propensity for renal stone formation. Hwang TI; Hill K; Schneider V; Pak CY J Clin Endocrinol Metab; 1988 Jan; 66(1):109-12. PubMed ID: 3335600 [TBL] [Abstract][Full Text] [Related]
29. The urinary excretion of oxalic acid and magnesium in oxalate urolithiasis. Takasaki E; Shimano E Invest Urol; 1967 Nov; 5(3):303-12. PubMed ID: 6073639 [No Abstract] [Full Text] [Related]
30. [Study of the influence of conditions during urine collection on measurement of the major constituents of urinary calculi]. Miyazaki Y; Ebisuno S; Kitagawa M; Morimoto S; Yasukawa S; Ohkawa T Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):881-8. PubMed ID: 3934443 [No Abstract] [Full Text] [Related]
31. The relation between the concentration of calcium salts in the urine and renal stone composition in patients with calcium-containing renal stones. Marshall RW; Cochran M; Robertson WG; Hodgkinson A; Nordin BE Clin Sci; 1972 Sep; 43(3):433-41. PubMed ID: 5077518 [No Abstract] [Full Text] [Related]
32. Relation between calcium oxalate hydrate form found in renal calculi and some urinary parameters. Conte A; Genestar C; Grases F Urol Int; 1990; 45(1):25-7. PubMed ID: 2305491 [TBL] [Abstract][Full Text] [Related]
33. Effectiveness and mode of action of orthophosphates in patients with calcareous renal calculi. Thomas WC Trans Am Clin Climatol Assoc; 1972; 83():113-24. PubMed ID: 5040108 [No Abstract] [Full Text] [Related]
34. Urinary magnesium and renal stones. White RW Lancet; 1969 Jan; 1(7586):156. PubMed ID: 4178270 [No Abstract] [Full Text] [Related]
35. Excretion of inhibitors of calcification in urine. Part I. Findings in control subjects and patients with renal stones. Oreopoulos DG; Walker D; Akriotis DJ; Roncari DA; Husdan H; Symvoulidis A; Deveber GA; Rapoport A; Reid DB Can Med Assoc J; 1975 Apr; 112(7):827-31. PubMed ID: 1122457 [TBL] [Abstract][Full Text] [Related]
36. The effects of probenecid and thiazides and their combination on the urinary excretion of electrolytes and on acid-base equilibrium. Garcia DA; Yendt ER Can Med Assoc J; 1970 Sep; 103(5):473-83. PubMed ID: 5469617 [TBL] [Abstract][Full Text] [Related]
37. [Magnesium excretion in recurrent calcium urolithiasis]. Pfab R; Hegemann M; Schütz W; Böttger I Urologe A; 1985 Sep; 24(5):296-8. PubMed ID: 4060380 [TBL] [Abstract][Full Text] [Related]
38. Urinary magnesium in response to an oral calcium load. Labeeuw M; Pozet N; Zech P; Traeger J Nephron; 1986; 43(2):158-9. PubMed ID: 3713947 [No Abstract] [Full Text] [Related]
39. Effects of magnesium oxide on the crystallization of calcium salts in urine in patients with recurrent nephrolithiasis. Fetner CD; Barilla DE; Townsend J; Pak CY J Urol; 1978 Oct; 120(4):399-401. PubMed ID: 702659 [TBL] [Abstract][Full Text] [Related]
40. [Renal tubular function in children with hypercalciuria]. Kovacević L; Kovacević S; Smoljanić Z; Kostić M; Peco-Antić A; Gajić M; Kovacević M; Jovanović O Srp Arh Celok Lek; 1998; 126(7-8):223-7. PubMed ID: 9863386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]